XP-828l

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2007
01220052007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
In a placebo-controlled clinical trial, the dietary supplement XP-828L (commercialized as Dermylex) demonstrated potential to… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2007
2007
Natural health products (NHPs) or complementary and alternative medicine (CAM) are commonly used to prevent disorders or support… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2007
2007
Advitech is the developer of XP-828L. Abstract Background: XP-828L, a protein extract obtained from sweet whey, has demonstrated… (More)
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 5
Is this relevant?
2006
2006
BACKGROUND XP-828L, a protein extract obtained from sweet whey, has demonstrated potential benefit for the treatment of mild to… (More)
Is this relevant?
2005
2005
BACKGROUND XP-828L is a nutraceutical compound obtained by the extraction of a growth factors-enriched protein fraction from… (More)
Is this relevant?